Page last updated: 2024-08-24

1,5-anhydroglucitol and Diabetes Mellitus, Type 2

1,5-anhydroglucitol has been researched along with Diabetes Mellitus, Type 2 in 104 studies

Research

Studies (104)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (3.85)	18.7374
1990's	17 (16.35)	18.2507
2000's	26 (25.00)	29.6817
2010's	48 (46.15)	24.3611
2020's	9 (8.65)	2.80

Authors

Authors	Studies
Hao, M; Huang, X; Li, M; Li, W; Liu, W; Xu, Y; Yan, D	1
Alfieri, S; Di Giuseppe, G; Dibner, C; Giaccari, A; Guessous, I; Jiménez-Sánchez, C; Jornayvaz, FR; Li, L; Maechler, P; Mezza, T; Quero, G; Schrauwen, P; Sinturel, F	1
Colodner, R; Hasanein, J; Hissin, N; Mirsky, N; Nachum, Z; Shwartz, N; Twafra, S; Yefet, E	1
Bao, Y; He, X; Ma, X; Shen, Y; Su, H; Wang, Y; Ying, L; Zhou, J; Zhu, W	1
Chen, C; Chen, J; Guo, H; Sun, Z; Tan, Y; Wang, B; Wang, X; Wang, Y; Yang, J; Yuan, Y	1
Hao, S; Li, H; Li, J; Lou, Q; Miller, JD; Yan, J; Yang, L; Yuan, X; Zuo, P	1
Dai, XX; Gao, MX; Shi, GL; Su, G; Yao, WF; Zhang, T; Zhuang, SW	1
Bao, Y; Hu, G; Lu, J; Lu, W; Ma, X; Mo, Y; Shen, Y; Si, Y; Zhang, L; Zhou, J; Zhu, W	1
Katsuno, T; Konishi, K; Koyama, H; Kusunoki, Y; Matsuo, T; Matsutani, S; Namba, M; Ohigashi, M; Osugi, K; Tsunoda, T; Washio, K	1
Adamski, J; Artati, A; Federici, M; Ghesquiere, B; Kappel, BA; Lehrke, M; Marx, N; Moellmann, J; Rau, M; Romeo, F; Schuett, K; Stoehr, R; Thiele, K	1
Boerwinkle, E; Friedrich, N; Köttgen, A; Li, M; Loomis, SJ; Maruthur, NM; Mei, H; Morrison, AC; Nauck, M; North, KE; Pankow, JS; Pietzner, M; Selvin, E; Teumer, A	1
Glodzik, W; Hohendorff, J; Kapusta, M; Kiec-Wilk, B; Klupa, T; Ludwig-Galezowska, A; Malecki, MT; Mrozinska, S; Parpan, T; Platek, T; Skupien, J; Szopa, M; Zapala, B	1
Kadowaki, T; Muto, S; Ouchi, Y; Seino, Y; Shimazaki, R	1
Bao, Y; He, X; Hu, X; Jia, W; Ma, X; Peng, J; Su, H; Wang, Y; Ying, L; Zhou, J	1
Bai, Y; Song, Y; Wang, Y; Yang, R	1
Glodzik, W; Hohendorff, J; Kapusta, M; Klupa, T; Malecki, MT; Matejko, B; Sani, CM; Skupien, J; Szopa, M; Ucieklak, D; Zapala, B	1
Chalmers, J; Cooper, ME; Hamet, P; Harrap, S; Juraschek, SP; Lazo, M; Marre, M; McEvoy, JW; Selvin, E; Wang, D; Williams, B; Woodward, M	1
Chin, SO; Choi, MC; Chon, S; Fraterrigo, G; Kim, YS; Kwon, MK; Lee, YJ; Oh, S; Pozzilli, P; Rhee, SY; Woo, JT	1
Aoyama, J; Igari, Y; Ishii, K; Matsumura, N; Motoyama, M; Nakano, H; Oba, K; Ouchi, M; Sekimizu, K; Suzuki, T; Watanabe, K; Yano, H	1
Araki, E; Furukawa, N; Goto, R; Ichimori, S; Iwashita, S; Kawashima, J; Kondo, T; Maeda, T; Matsumura, T; Matsuo, T; Matsuo, Y; Motoshima, H; Nishida, K; Sekigami, T; Shimoda, S	1
Kawata, T; Matsubara, F; Nagai, Y; Nakamura, Y; Ohshige, T; Ohta, A; Sakai, K; Tanaka, Y; Tenjin, A; Terashima, Y; Tsukiyama, S	1
Balis, DA; Meininger, G; Tong, C	1
Abdul Kader, S; Al Muftah, WA; Al-Homsi, H; Al-Mahmoud, KA; Al-Obaidli, A; Chidiac, OM; Karoly, ED; Kocher, T; McKeon, C; Mook-Kanamori, DO; Mook-Kanamori, MJ; Rowe, J; Sekkal Gherbi, W; Selim, MM; Suhre, K; Takiddin, AH; Yousri, NA; Zirie, MA	1
Borowska, M; Dworacka, M; Dworacki, G; Iskakova, S; Krzyżagórska, E; Wesołowska, A	1
Dworacka, M; Dworacki, G; Iskakova, S; Wesołowska, A; Winiarska, H; Wysocka, E	1
Mori, H; Okada, Y; Tanaka, Y; Torimoto, K	1
Aoki, C; Aso, Y; Kato, K; Niitani, M; Suzuki, K; Tanaka, S; Tomotsune, T	1
Parrinello, CM; Selvin, E	1
Chan, CL; Kelsey, M; Nadeau, KJ; Newnes, L; Pyle, L; Zeitler, PS	1
Bao, Y; Deng, Z; Hao, Y; Hu, X; Jia, W; Luo, Y; Ma, X; Zhou, J	1
Brown, Z; Gooley, TA; Hirsch, IB; Wright, LA	1
Brown, Z; Coley, RY; Delaney, SS	1
Ako, J; Fujiyoshi, K; Hashikata, T; Hashimoto, T; Kakizaki, R; Kameda, R; Kitasato, L; Maekawa, E; Namba, S; Nemoto, T; Shimohama, T; Tojo, T; Yamaoka-Tojo, M	1
Amaya, N; Arakawa, K; Fukuoka, Y; Ikeda, H; Ishida, K; Kaseno, K; Lee, JD; Morishita, T; Sato, T; Shiomi, Y; Tada, H; Tama, N; Uzui, H	1
Fortuna, D; McCloskey, LJ; Stickle, DF	1
Hasslacher, C; Kulozik, F	1
Jeon, WS; Lee, WY; Oh, KW; Park, CY; Park, SE; Park, SW; Rhee, EJ	1
Amaya, N; Fukuoka, Y; Ikeda, H; Ishida, K; Kaseno, K; Lee, JD; Morishita, T; Tada, H; Uzui, H	1
Baumgartner, A; Chan, CL; Kelsey, MM; Nadeau, KJ; Newnes, L; Pyle, L; Zeitler, PS	1
Guo, M; Liu, Z; Ma, C; Sheng, J	1
Aoki, K; Nakajima, S; Nezu, U; Shinoda, K; Terauchi, Y	1
Heng, X; Li, S; Sheng, H; Wang, Y; Yu, C	1
Bilo, HJ; Diamant, M; Schindhelm, RK; Slingerland, RJ	1
Choi, ES; Kim, JH; Kim, SW; Lee, WY; Oh, KW; Park, CY; Park, HS; Park, SW; Rhee, EJ; Won, JC	1
Buse, JB; Dungan, KM; Fahrbach, JL; Herman, WH; Jiang, H; Martin, S; Wolffenbuttel, BH	1
Kublaoui, BM; Oden, JD; Shah, S; White, PC	1
Barrow, BA; Dudley, C; Farmer, AJ; Gloyn, AL; Grew, JP; Klyne, R; McCarthy, MI; Owen, KR; Pal, A; Selwood, MP	1
Ban, N; Endo, K; Kawana, H; Miyashita, Y; Murano, T; Nagayama, D; Nagumo, A; Ohira, M; Oyama, T; Saiki, A; Shirai, K; Watanabe, H; Yamaguchi, T	1
Hanafusa, T; Imagawa, A; Kasayama, S; Koga, M; Mukai, M; Murai, J; Saito, H	1
Keers, JC; Kerstens, MN; Kreugel, G; Wolffenbuttel, BH	1
Cho, SW; Hwang-Bo, Y; Jang, HC; Jung, HS; Kim, MJ; Kim, SY; Park, KS	1
Davis, KE; Januszewski, AS; Jenkins, AJ; Karschimkus, C; O'Neal, D; Ward, G	1
Kishimoto, M; Noda, M	1
Kim, WJ; Lee, KB; Lee, WY; Oh, KW; Park, CY; Park, SE; Park, SW; Rhee, EJ	1
Lei, CH; Sun, ZL; Wang, Y; Wang, YP; Zhang, YL	1
Hamano, K; Ishibashi, S; Kiyono, K; Kusaka, I; Nagasaka, S; Ogata, H; Struzik, ZR; Suzuki, H; Tokuyama, K; Tsuchita, T; Yamada, N; Yamamoto, Y	1
Ahn, HY; Kim, SW; Kim, WJ; Kim, YJ; Lee, WY; Oh, KW; Park, CY; Park, HS; Park, SE; Park, SW; Rhee, EJ; Song, SJ	1
Dou, JT; Lu, JM; Lü, ZH; Ma, FL; Mu, YM; Sun, J; Wang, XL; Yang, GQ; Zheng, H	1
Arakaki, RF; Buse, JB; Dungan, KM; Fahrbach, JL; Herman, WH; Jacobson, JG; Jiang, HH	1
Cao, X; Huang, Z; Li, Y; Liu, J; Liu, L; Wan, X	1
Ando, K; Irako, T; Nishimura, R; Sakamoto, M; Tsujino, D; Utsunomiya, K	1
Dungan, KM	1
Adachi, I; Ishikawa, F; Kato, A; Kunimatsu, T; Takeshita, K; Yamashita, Y	1
Dworacka, M; Kuczynski, S; Szczawinska, K; Szymanska, M; Wierusz-Wysocka, B; Winiarska, H	1
Inoue, T; Kashiwabara, A; Kawasaki, T; Ogata, N; Sawashige, K; Sekino, N; Yamanouchi, T	1
Araki, A; Sasamoto, K; Shirabe, S; Yamanouchi, T; Yanagawa, T	1
Akanuma, H; Ichiyanagi, K; Kawasaki, T; Ogata, N; Sakai, T; Watanabe, H; Yamanouchi, T	1
Ammirati, EB; Cole, TG; Gautille, T; Houghton, S; McGill, JB; Nowatzke, W; Sarno, MJ	1
Kawamori, R; Miwa, S; Ohmura, C; Tanaka, Y; Watada, H	1
Dworacka, M; Winiarska, H	1
Del Prato, S; Hanefeld, M; Karrei, K; Koehler, C; Temelkova-Kurktschiev, T	1
Abramczyk, M; Borowska, M; Dworacka, M; Kuczynski, S; Szczawinska, K; Winiarska, H	1
Gotoh, M; Hirooka, Y; Iguchi, A; Li, C; Yatoh, M	1
Buse, JB; Button, EA; Dungan, KM; Kato, S; Kelly, MM; Largay, J; Wittlin, S	1
Okahata, S; Terauchi, Y; Tobe, K	1
Asano, T; Hiramatsu, S; Ogo, A; Watanabe, A; Yoshizumi, H	1
Abramczyk, M; Bobkiewicz-Kozlowska, T; Borowska, M; Dworacka, M; Dworacki, G; Winiarska, H	1
Fei, X; Jing, F; Jun, L; Wang, Y; Yong, Z; Zhang, J; Zhu, M	1
Bobkiewicz-Kozłowska, T; Dworacka, M; Wegner, M; Winiarska, H	1
Allemann, S; Christ, E; Diem, P; Keller, U; Riesen, W; Schmidlin, K; Stahl, M; Stettler, C; Zwahlen, M	1
Button, EA; Gorczynska-Kosiorz, S; Klupa, T; Malecki, MT; Sieradzki, J; Skupien, J; Wanic, K	1
Arai, K; Kamada, T; Kawamori, R; Kishimoto, M; Kubota, M; Morishima, T; Yamasaki, Y	1
Chusney, GD; Pickup, JC	1
Akaoka, L; Funato, H; Kawasaki, T; Miyashita, H; Ogata, N; Sekino, N; Tagaya, T; Yamanouchi, T	1
Pitkänen, E	1
Kobayashi, I; Tsukui, S	1
Fukumura, Y; Kobayashi, I; Tsukui, S	1
Fukasawa, H; Hotta, N; Kakuta, H; Koh, N; Naruse, K; Sakakibara, F; Takeuchi, N; Yamada, K; Yamada, T	1
Kawai, K; Kawakami, Y; Matsushima, T; Odawara, M; Okuda, Y; Sone, H; Yamaoka, T; Yamashita, K	1
Azukari, K; Kondo, M; Yoshida, T; Yoshioka, K	1
Arisaka, T; Honda, N; Kawamori, R; Kinoshita, J; Kurahashi, Y; Mochizuki, K; Nakamura, M; Tohjima, T; Watanabe, K; Yamamoto, S; Yoshimoto, T	1
Aso, Y; Inukai, T; Takemura, Y	1
Akaoka, I; Funato, H; Inoue, T; Kawasaki, T; Koshibu, E; Miyashita, H; Ogata, N; Yamanouchi, T; Yoshimura, T	1
Kondo, T; Miyakawa, M; Shimada, N; Shirasaya, K; Takahashi, E; Yoshida, K	1
Akanuma, Y	1
Aiso, Y; Fujimori, S; Inoue, T; Kashiwabara, A; Kawasaki, T; Tanabe, T; Yamanouchi, T; Yoshimura, T	1
Akanuma, Y; Kawakami, M; Ohashi, Y; Saito, Y; Tanaka, A; Yamada, N	1
Fang, J; Shen, Z; Shi, H; Yang, X; Zhu, X	1
Akaoka, I; Minoda, S; Miyashita, H; Moromizato, H; Shinohara, T; Yamanouchi, T	1
Hisatomi, A; Ishii, H; Nakashima, N; Nawata, H; Umeda, F; Yamauchi, T	1
Akanuma, H; Akanuma, Y; Akaoka, I; Minoda, S; Miyashita, H; Yabuuchi, M; Yamanouchi, T	1
Akanuma, H; Aoyagi, T; Kobayashi, T; Sakaguchi, T; Umezawa, H; Wada, T	1
Akanuma, H; Akanuma, Y; Fukuzawa, N; Morita, M; Yamanouchi, T	1
Akanuma, H; Akanuma, Y; Akaoka, I; Asano, T; Konishi, C; Yamanouchi, T	1

Reviews

4 review(s) available for 1,5-anhydroglucitol and Diabetes Mellitus, Type 2

Article	Year
Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management. Current diabetes reports, 2014, Volume: 14, Issue:11 Topics: Biomarkers; Blood Glucose; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Prognosis; Prospective Studies; Serum Albumin	2014
1,5-anhydro-D-glucitol: a novel marker of glucose excursions. International journal of clinical practice. Supplement, 2002, Issue:129 Topics: Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Glycated Hemoglobin; Humans; Hyperglycemia; Postprandial Period	2002
[Postprandial hyperglycemia]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Sep-28, Volume: Suppl 3 Topics: Arteriosclerosis; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Endothelium, Vascular; Evidence-Based Medicine; Glucose; Hyperglycemia; Hyperthyroidism; Insulin; Insulin Resistance; Insulin Secretion; Liver Cirrhosis; Oxidative Stress; Postprandial Period	2006
[Physiopathology and therapy of diabetes mellitus]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1999, Sep-10, Volume: 88, Issue:9 Topics: Animals; Arteriosclerosis; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Humans; Insulin Resistance; Obesity; Patient Education as Topic	1999

Trials

24 trial(s) available for 1,5-anhydroglucitol and Diabetes Mellitus, Type 2

Article	Year
Effects of Glucose Fluctuation Targeted Intervention on the Prognosis of Patients with Type 2 Diabetes following the First Episode of Cerebral Infarction. Journal of diabetes research, 2020, Volume: 2020 Topics: Aged; Blood Glucose; Cerebral Infarction; Cholesterol, LDL; Deoxyglucose; Diabetes Mellitus, Type 2; Diet Therapy; Exercise; Female; Functional Status; Glycated Hemoglobin; Glycemic Control; Hand Strength; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Muscle Strength; Patient Care Planning; Postprandial Period; Quality of Life; Treatment Outcome	2020
Association between 1,5-Anhydroglucitol and Acute C Peptide Response to Arginine among Patients with Type 2 Diabetes. Journal of diabetes research, 2020, Volume: 2020 Topics: Adult; Arginine; Biomarkers; Blood Glucose; C-Peptide; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Insulin-Secreting Cells; Male; Middle Aged; Pancreatic Function Tests; Predictive Value of Tests	2020
Efficacy and safety of saxagliptin in combination with insulin in Japanese patients with type 2 diabetes mellitus: a 16-week double-blind randomized controlled trial with a 36-week open-label extension. Expert opinion on pharmacotherapy, 2017, Volume: 18, Issue:18 Topics: Adamantane; Aged; Blood Glucose; C-Peptide; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptides; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Japan; Male; Middle Aged; Placebo Effect; Treatment Outcome	2017
Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial. Diabetes, obesity & metabolism, 2019, Volume: 21, Issue:8 Topics: Aged; Antihypertensive Agents; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gliclazide; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Intention to Treat Analysis; Male; Microvessels; Middle Aged; Perindopril; Proportional Hazards Models; Risk Factors; Treatment Outcome	2019
Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy. Endocrine journal, 2013, Volume: 60, Issue:10 Topics: Aged; Asian People; Blood Glucose; Blood Glucose Self-Monitoring; Body Mass Index; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Triazoles	2013
Comparison of the hypoglycemic effect of sitagliptin versus the combination of mitiglinide and voglibose in drug-naïve Japanese patients with type 2 diabetes. Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:17 Topics: Aged; Asian People; Blood Glucose; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Inositol; Insulin; Isoindoles; Male; Middle Aged; Pyrazines; Serum Albumin; Sitagliptin Phosphate; Triazoles	2013
Effect of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, on measurement of serum 1,5-anhydroglucitol. Journal of diabetes, 2014, Volume: 6, Issue:4 Topics: Blood Glucose; Canagliflozin; Deoxyglucose; Diabetes Mellitus, Type 2; Double-Blind Method; Follow-Up Studies; Glucosides; Glycated Hemoglobin; Humans; Prognosis; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes	2014
Statins in low doses reduce VEGF and bFGF serum levels in patients with type 2 diabetes mellitus. Pharmacology, 2014, Volume: 93, Issue:1-2 Topics: Adult; Aged; Blood Glucose; Cholesterol; Deoxyglucose; Diabetes Mellitus, Type 2; Fibroblast Growth Factor 2; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Middle Aged; Triglycerides; Vascular Endothelial Growth Factor A	2014
Circulating CD3+56+ cell subset in pre-diabetes. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2014, Volume: 122, Issue:2 Topics: Aged; Blood Glucose; CD3 Complex; CD56 Antigen; Deoxyglucose; Diabetes Mellitus, Type 2; Fasting; Glycated Hemoglobin; Humans; Hyperglycemia; Lipids; Male; Middle Aged; Natural Killer T-Cells; Plaque, Atherosclerotic	2014
Low levels of 1,5-anhydro-D-glucitol are associated with vascular endothelial dysfunction in type 2 diabetes. Cardiovascular diabetology, 2014, Jun-13, Volume: 13 Topics: Adult; Aged; Biomarkers; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Humans; Male; Middle Aged	2014
Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin. Pediatric diabetes, 2016, Volume: 17, Issue:3 Topics: Adolescent; Biomarkers; Child; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Mass Screening; Obesity; Prediabetic State; Serum Albumin	2016
Comparison of pre- vs. postmeal administration of miglitol for 3 months in type 2 diabetic patients. Diabetes, obesity & metabolism, 2008, Volume: 10, Issue:10 Topics: 1-Deoxynojirimycin; Analysis of Variance; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Administration Schedule; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Postprandial Period	2008
Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes. Diabetes technology & therapeutics, 2011, Volume: 13, Issue:7 Topics: Aged; Body Mass Index; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Male; Materials Testing; Middle Aged; Needles; Netherlands; Obesity; Patient Preference; Practice Guidelines as Topic; Self Administration	2011
Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): crossover pilot study (J-VICTORIA study). Cardiovascular diabetology, 2012, Aug-06, Volume: 11 Topics: Adamantane; Adult; Aged; Biomarkers; Blood Glucose; C-Peptide; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Schedule; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Japan; Male; Middle Aged; Monitoring, Ambulatory; Natriuretic Peptide, Brain; Nitriles; Pilot Projects; Plasminogen Activator Inhibitor 1; Postprandial Period; Predictive Value of Tests; Pyrazines; Pyrrolidines; Serum Albumin; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles; Vildagliptin	2012
Usefulness of troglitazone administration to obese hyperglycaemic patients with near-normoglycaemia. Diabetes, obesity & metabolism, 2003, Volume: 5, Issue:3 Topics: Adult; Aged; Blood Glucose; Chromans; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Obesity; Thiazoles; Thiazolidinediones; Troglitazone	2003
Effect of antidiabetic medications on microalbuminuria in patients with type 2 diabetes. Metabolism: clinical and experimental, 2004, Volume: 53, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Blood Glucose; Cholesterol; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Gliclazide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Thiazolidinediones	2004
Efficacy and safety of once daily gliclazide (20 mg/day) compared with nateglinide. Endocrine journal, 2004, Volume: 51, Issue:4 Topics: Adult; Cross-Over Studies; Cyclohexanes; Deoxyglucose; Diabetes Mellitus, Type 2; Gliclazide; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Lipoproteins, LDL; Malondialdehyde; Nateglinide; Phenylalanine; Prospective Studies; Serum Albumin; Thiobarbituric Acid Reactive Substances	2004
Disproportionately elevated proinsulin levels in type 2 diabetic patients treated with sulfonylurea. International journal of clinical pharmacology and therapeutics, 2006, Volume: 44, Issue:1 Topics: Aged; Blood Glucose; Body Mass Index; C-Peptide; Caloric Restriction; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fasting; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Multivariate Analysis; Patient Selection; Proinsulin; Sulfonylurea Compounds	2006
Short term intensive insulin therapy improves insulin secretion significantly in type 2 diabetic patients. Fukuoka igaku zasshi = Hukuoka acta medica, 2006, Volume: 97, Issue:9 Topics: Aged; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Middle Aged; Time Factors; Treatment Outcome	2006
1,5-Anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM. Diabetes care, 1995, Volume: 18, Issue:8 Topics: Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Drug Administration Schedule; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Isomerism; Male; Middle Aged; Regression Analysis	1995
Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control. Lancet (London, England), 1996, Jun-01, Volume: 347, Issue:9014 Topics: Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Administration Schedule; Evaluation Studies as Topic; Female; Follow-Up Studies; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Isomerism; Male; Middle Aged; Prospective Studies; Sensitivity and Specificity; Time Factors	1996
Predicting long-term glycemic control of post-educational type II diabetic patients by evaluating serum 1,5-anhydroglucitol levels. Diabetes research and clinical practice, 1996, Volume: 34, Issue:2 Topics: Aged; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Evaluation Studies as Topic; Female; Hospitalization; Humans; Isomerism; Linear Models; Male; Middle Aged; Patient Education as Topic; Prognosis; Time Factors	1996
The influence of traditional Chinese herbal drugs on serum 1, 5-anhydroglucitol levels. Diabetes research and clinical practice, 2000, Volume: 50, Issue:2 Topics: Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Female; Humans; Male; Medicine, Kampo; Middle Aged	2000
A double-blind trial on the effects of atorvastatin on glycemic control in Japanese diabetic patients with hypercholesterolemia. Clinica chimica acta; international journal of clinical chemistry, 2001, Volume: 312, Issue:1-2 Topics: Adult; Aged; Anticholesteremic Agents; Apolipoproteins; Atorvastatin; Blood Glucose; Cholesterol; Deoxyglucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fructosamine; Glycated Hemoglobin; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Pyrroles	2001

Other Studies

76 other study(ies) available for 1,5-anhydroglucitol and Diabetes Mellitus, Type 2

Article	Year
Quantification of Glucose, fructose and 1,5-Anhydroglucitol in plasma of diabetic patients by ultra performance liquid chromatography tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2022, Jun-01, Volume: 1200 Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Fructose; Glucose; Humans; Reproducibility of Results; Tandem Mass Spectrometry	2022
Circulating 1,5-Anhydroglucitol as a Biomarker of ß-cell Mass Independent of a Diabetes Phenotype in Human Subjects. The Journal of clinical endocrinology and metabolism, 2022, 09-28, Volume: 107, Issue:10 Topics: Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Phenotype; Prediabetic State; Research Subjects	2022
Inverse association between 1,5-anhydroglucitol and neonatal diabetic complications. Endocrine, 2019, Volume: 66, Issue:2 Topics: Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Fructosamine; Glycated Hemoglobin; Humans; Infant, Newborn; Infant, Newborn, Diseases; Pregnancy; Pregnancy in Diabetics; Prospective Studies; Risk Factors	2019
1,5-Anhydroglucitol × glycated hemoglobin A Acta diabetologica, 2020, Volume: 57, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; China; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Islets of Langerhans; Male; Middle Aged; Young Adult	2020
Reference intervals for serum 1,5-anhydroglucitol of a population with normal glucose tolerance in Jiangsu Province. Journal of diabetes, 2020, Volume: 12, Issue:6 Topics: Adult; Aged; Biomarkers; Blood Glucose; China; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Male; Middle Aged; Reference Values; Uric Acid; Young Adult	2020
Effect of 1,5-anhydroglucitol levels on culprit plaque rupture in diabetic patients with acute coronary syndrome. Cardiovascular diabetology, 2020, 05-30, Volume: 19, Issue:1 Topics: Acute Coronary Syndrome; Aged; Biomarkers; Blood Glucose; Coronary Artery Disease; Coronary Vessels; Deoxyglucose; Diabetes Mellitus, Type 2; Dinoprost; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Rupture, Spontaneous; Ultrasonography, Interventional	2020
Association of time in range with hemoglobin A1c, glycated albumin and 1,5-anhydro-d-glucitol. Journal of diabetes investigation, 2021, Volume: 12, Issue:6 Topics: Adult; Aged; Blood Glucose Self-Monitoring; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Glucose Metabolism Disorders; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycemic Control; Humans; Male; Middle Aged; Retrospective Studies; Serum Albumin; Time Factors	2021
Human and mouse non-targeted metabolomics identify 1,5-anhydroglucitol as SGLT2-dependent glycemic marker. Clinical and translational medicine, 2021, Volume: 11, Issue:6 Topics: Animals; Benzhydryl Compounds; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Double-Blind Method; Glucosides; Humans; Metabolome; Mice; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors	2021
Genome-wide association study of 1,5-anhydroglucitol identifies novel genetic loci linked to glucose metabolism. Scientific reports, 2017, 06-06, Volume: 7, Issue:1 Topics: Aged; Black or African American; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Glucose; Glycated Hemoglobin; Humans; Hyperglycemia; Insulin; Male; Middle Aged; Minichromosome Maintenance Complex Component 6; Sodium-Glucose Transporter 1; White People	2017
A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus. Endocrine, 2017, Volume: 57, Issue:2 Topics: Adult; Aged; Benzhydryl Compounds; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucokinase; Glucosides; Glycosuria; Hepatocyte Nuclear Factor 1-alpha; Humans; Hypoglycemic Agents; Male; Middle Aged; Mutation; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Young Adult	2017
A decrease in serum 1,5-anhydroglucitol levels is associated with the presence of a first-degree family history of diabetes in a Chinese population with normal glucose tolerance. Diabetic medicine : a journal of the British Diabetic Association, 2018, Volume: 35, Issue:1 Topics: Adult; Aged; Asian People; China; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Family; Female; Glucose Tolerance Test; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Logistic Models; Male; Middle Aged; Serum Albumin; Young Adult	2018
Serum 1,5-Anhydroglucitol Concentrations Remain Valid as a Glycemic Control Marker In Diabetes with Earlier Chronic Kidney Disease Stages. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2019, Volume: 127, Issue:4 Topics: Adult; Aged; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Renal Insufficiency, Chronic; Uric Acid	2019
A decision algorithm to identify patients with high probability of monogenic diabetes due to HNF1A mutations. Endocrine, 2019, Volume: 64, Issue:1 Topics: Adult; Aged; Algorithms; Biomarkers; C-Reactive Protein; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucokinase; Hepatocyte Nuclear Factor 1-alpha; Humans; Male; Middle Aged; Young Adult	2019
Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus. Diabetes technology & therapeutics, 2013, Volume: 15, Issue:6 Topics: Adolescent; Adult; Aged; Analysis of Variance; Area Under Curve; Biomarkers; Blood Glucose; Blood Glucose Self-Monitoring; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Hyperglycemia; Male; Mass Screening; Middle Aged; Predictive Value of Tests; Republic of Korea	2013
Serum uric acid in relation to serum 1,5-anhydroglucitol levels in patients with and without type 2 diabetes mellitus. Clinical biochemistry, 2013, Volume: 46, Issue:15 Topics: Aged; Aged, 80 and over; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Male; Middle Aged; Outpatients; Regression Analysis; Uric Acid	2013
1,5-Anhydroglucitol in saliva is a noninvasive marker of short-term glycemic control. The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:3 Topics: Adult; Aged; Biomarkers; Blood Glucose; Case-Control Studies; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Humans; Male; Mass Spectrometry; Metabolomics; Middle Aged; Saliva; Young Adult	2014
Add-on treatment with teneligliptin ameliorates glucose fluctuations and improves glycemic control index in Japanese patients with type 2 diabetes on insulin therapy. Diabetes technology & therapeutics, 2014, Volume: 16, Issue:12 Topics: Aged; C-Reactive Protein; Combined Modality Therapy; Deoxyglucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Dipeptidyl-Peptidase IV Inhibitors; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Insulin; Japan; Male; Middle Aged; Monitoring, Ambulatory; Pilot Projects; Prospective Studies; Pyrazoles; Serum Albumin; Thiazolidines	2014
1,5-anhydroglucitol is associated with early-phase insulin secretion in chinese patients with newly diagnosed type 2 diabetes mellitus. Diabetes technology & therapeutics, 2015, Volume: 17, Issue:5 Topics: Adult; Aged; Asian People; China; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Homeostasis; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged; Serum Albumin	2015
1,5-ANHYDROGLUCITOL AND NEONATAL COMPLICATIONS IN PREGNANCY COMPLICATED BY DIABETES. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2015, Volume: 21, Issue:7 Topics: Adult; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Humans; Hypoglycemia; Infant, Newborn; Infant, Newborn, Diseases; Male; Pregnancy; Pregnancy Complications	2015
1,5-Anhydroglucitol: a new predictor of neonatal birth weight in diabetic pregnancies. European journal of obstetrics, gynecology, and reproductive biology, 2015, Volume: 189 Topics: Biomarkers; Birth Weight; Cohort Studies; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Gestational Age; Glycated Hemoglobin; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy in Diabetics; Retrospective Studies	2015
Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetes. Heart and vessels, 2016, Volume: 31, Issue:8 Topics: Adiponectin; Aged; Deoxyglucose; Diabetes Mellitus, Type 2; Diastole; Dipeptidyl-Peptidase IV Inhibitors; Echocardiography; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans; Japan; Linear Models; Male; Middle Aged; Pyrazoles; Thiazolidines; Ventricular Function, Left	2016
Effect of postprandial hyperglycaemia on coronary flow reserve in patients with impaired glucose tolerance and type 2 diabetes mellitus. Diabetes & vascular disease research, 2015, Volume: 12, Issue:6 Topics: Aged; Aged, 80 and over; Coronary Circulation; Coronary Vessels; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose; Glucose Intolerance; Humans; Hyperglycemia; Male; Middle Aged	2015
Model analysis of effect of canagliflozin (Invokana), a sodium-glucose cotransporter 2 inhibitor, to alter plasma 1,5-anhydroglucitol. Clinica chimica acta; international journal of clinical chemistry, 2016, Jan-15, Volume: 452 Topics: Canagliflozin; Deoxyglucose; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Models, Biological; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors	2016
Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin. Journal of diabetes, 2016, Volume: 8, Issue:5 Topics: Aged; Albuminuria; Alpha-Globulins; Biomarkers; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Regression Analysis; Renal Insufficiency, Chronic; Serum Albumin; Severity of Illness Index	2016
The association of serum glycated albumin with the prevalence of diabetic retinopathy in Korean patients with type 2 diabetes mellitus. Diabetes research and clinical practice, 2016, Volume: 116 Topics: Biomarkers; Blood Glucose; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Republic of Korea; Serum Albumin	2016
Association of CD34/CD133/VEGFR2-Positive Cell Numbers with Eicosapentaenoic Acid and Postprandial Hyperglycemia in Patients with Coronary Artery Disease. International journal of cardiology, 2016, Oct-15, Volume: 221 Topics: AC133 Antigen; Aged; Antigens, CD34; Cell Count; Coronary Artery Disease; Deoxyglucose; Diabetes Mellitus, Type 2; Eicosapentaenoic Acid; Endothelium, Vascular; Female; Humans; Hyperglycemia; Male; Middle Aged; Neovascularization, Pathologic; Risk Factors; Stem Cells; Vascular Endothelial Growth Factor Receptor-2	2016
Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes. Pediatric diabetes, 2017, Volume: 18, Issue:7 Topics: Adolescent; Area Under Curve; Biomarkers; Blood Glucose; Child; Cohort Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Male; Monitoring, Ambulatory; Prediabetic State; Reproducibility of Results; Serum Albumin	2017
Excretion rates of 1,5-anhydro-D-glucitol, uric acid and microalbuminuria as glycemic control indexes in patients with type 2 diabetes. Scientific reports, 2017, 03-10, Volume: 7 Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Retrospective Studies; ROC Curve; Uric Acid; Young Adult	2017
Determination of glycemic monitoring marker 1,5-anhydroglucitol in plasma by liquid chromatography-electrospray tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2008, Nov-15, Volume: 875, Issue:2 Topics: Biomarkers; Case-Control Studies; Chromatography, Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Humans; Linear Models; Male; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Sex Characteristics; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry	2008
Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients: response to Stettler et al. Diabetes care, 2008, Volume: 31, Issue:11 Topics: Albuminuria; Blood Glucose; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Humans; Multivariate Analysis; Postprandial Period	2008
1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes. Diabetes research and clinical practice, 2009, Volume: 84, Issue:1 Topics: Adult; Aged; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Linear Models; Male; Middle Aged; Prediabetic State; Young Adult	2009
Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes. The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Asian People; Black People; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Ethnicity; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Racial Groups; White People	2009
Screening for type 2 diabetes in obese youth. Pediatrics, 2009, Volume: 124, Issue:2 Topics: Adolescent; Age Factors; Blood Glucose; Body Mass Index; Child; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperglycemia; Insulin; Insulin Resistance; Male; Mass Screening; Obesity; Predictive Value of Tests; ROC Curve; Texas	2009
Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes. Diabetes care, 2010, Volume: 33, Issue:2 Topics: Adolescent; Adult; Age of Onset; Blood Glucose; Body Mass Index; Child; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Glucokinase; Glucose Tolerance Test; Glycated Hemoglobin; Hepatocyte Nuclear Factor 1-alpha; Humans; Insulin-Secreting Cells; Mutation; Prognosis; ROC Curve; Young Adult	2010
Improvement of postprandial hyperglycemia and arterial stiffness upon switching from premixed human insulin 30/70 to biphasic insulin aspart 30/70. Metabolism: clinical and experimental, 2011, Volume: 60, Issue:1 Topics: Aged; Arteries; Biphasic Insulins; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Aspart; Insulin, Isophane; Male; Middle Aged	2011
Serum 1,5-anhydroglucitol levels in patients with fulminant type 1 diabetes are lower than those in patients with type 2 diabetes. Clinical biochemistry, 2010, Volume: 43, Issue:15 Topics: Adult; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged	2010
Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus. Acta diabetologica, 2013, Volume: 50, Issue:4 Topics: Adult; Aged; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Monitoring, Physiologic	2013
Plasma 1,5 anhydroglucitol levels, a measure of short-term glycaemia: assay assessment and lower levels in diabetic vs. non-diabetic subjects. Diabetes research and clinical practice, 2012, Volume: 95, Issue:1 Topics: Adult; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged	2012
A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers. Cardiovascular diabetology, 2011, Dec-22, Volume: 10 Topics: 1-Deoxynojirimycin; Aged; Biomarkers; Blood Glucose; Case-Control Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Middle Aged; Monitoring, Physiologic; Pilot Projects; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles	2011
Serum 1,5-anhydroglucitol concentrations are a reliable index of glycemic control in type 2 diabetes with mild or moderate renal dysfunction. Diabetes care, 2012, Volume: 35, Issue:2 Topics: Blood Glucose; Chronic Disease; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Glomerular Filtration Rate; Humans; Kidney Diseases	2012
A study on the association of serum 1,5-anhydroglucitol levels and the hyperglycaemic excursions as measured by continuous glucose monitoring system among people with type 2 diabetes in China. Diabetes/metabolism research and reviews, 2012, Volume: 28, Issue:4 Topics: Adult; Aged; Area Under Curve; Blood Glucose; Blood Glucose Self-Monitoring; China; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Young Adult	2012
The lack of long-range negative correlations in glucose dynamics is associated with worse glucose control in patients with diabetes mellitus. Metabolism: clinical and experimental, 2012, Volume: 61, Issue:7 Topics: Adult; Blood Glucose; C-Peptide; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Serum Albumin	2012
Serum 1,5-anhydroglucitol is associated with diabetic retinopathy in Type 2 diabetes. Diabetic medicine : a journal of the British Diabetic Association, 2012, Volume: 29, Issue:9 Topics: Albuminuria; Biomarkers; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Logistic Models; Male; Middle Aged; Prevalence; Republic of Korea; Risk Factors	2012
Correlation between 1,5-anhydroglucitol and glycemic excursions in type 2 diabetic patients. Chinese medical journal, 2011, Volume: 124, Issue:22 Topics: Aged; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Postprandial Period	2011
Potential for use of 1,5-anhydroglucitol when initiating insulin therapy in people with type 2 diabetes and suboptimal control with oral antidiabetic drugs. Diabetes research and clinical practice, 2012, Volume: 96, Issue:3 Topics: Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin Glargine; Insulin Lispro; Insulin, Long-Acting; Male; Middle Aged; Treatment Outcome; Weight Gain	2012
Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy. Diabetes technology & therapeutics, 2012, Volume: 14, Issue:9 Topics: Adult; Aged; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Fructosamine; Glucose Tolerance Test; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Logistic Models; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Remission Induction; Time Factors	2012
Predicting outcomes and assessing control with alternate glycemic markers. Diabetes technology & therapeutics, 2012, Volume: 14, Issue:9 Topics: Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Humans; Hypoglycemic Agents; Insulin; Male	2012
Protective effects of dietary 1,5-anhydro-D-glucitol as a blood glucose regulator in diabetes and metabolic syndrome. Journal of agricultural and food chemistry, 2013, Jan-23, Volume: 61, Issue:3 Topics: Administration, Oral; alpha-Glucosidases; Animals; Blood Glucose; Cholesterol; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Glycoside Hydrolase Inhibitors; Glycosuria; Hyperglycemia; Intestines; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL	2013
Postprandial plasma fructose level is associated with retinopathy in patients with type 2 diabetes. Metabolism: clinical and experimental, 2004, Volume: 53, Issue:5 Topics: Aged; Blood Glucose; Blood Pressure; Body Mass Index; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Female; Fructose; Glycated Hemoglobin; Humans; Male; Middle Aged; Postprandial Period; Prevalence	2004
Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay. Diabetes care, 2004, Volume: 27, Issue:8 Topics: Adult; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Longitudinal Studies; Time Factors	2004
The application of plasma 1,5-anhydro-D-glucitol for monitoring type 2 diabetic patients. Disease markers, 2005, Volume: 21, Issue:3 Topics: Adult; Aged; Blood Glucose; Blood Glucose Self-Monitoring; Cardiovascular System; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose; Glycated Hemoglobin; Humans; Male; Middle Aged; Multivariate Analysis; Regression Analysis	2005
Fluctuations in glycaemia in clinical diabetes mellitus type 2 are not associated with carotid intima-media thickening. Diabetes & vascular disease research, 2004, Volume: 1, Issue:1 Topics: Blood Glucose; Carotid Artery, Common; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hyperglycemia; Middle Aged; Tunica Intima; Tunica Media; Ultrasonography	2004
Serum uric acid concentrations in type 2 diabetes: its significant relationship to serum 1,5-anhydroglucitol concentrations. Endocrine regulations, 2005, Volume: 39, Issue:4 Topics: Adult; Aged; Blood Glucose; Body Mass Index; Cholesterol; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Glycated Hemoglobin; Humans; Linear Models; Male; Middle Aged; Sex Characteristics; Uric Acid	2005
1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes care, 2006, Volume: 29, Issue:6 Topics: Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Humans; Hyperglycemia; Monitoring, Ambulatory; Monitoring, Physiologic; Postprandial Period; Reproducibility of Results	2006
Pro-atherogenic alterations in T-lymphocyte subpopulations related to acute hyperglycaemia in type 2 diabetic patients. Circulation journal : official journal of the Japanese Circulation Society, 2007, Volume: 71, Issue:6 Topics: Acute Disease; Aged; Antigens, CD; Blood Glucose; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Coronary Artery Disease; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fasting; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Lipids; Lymphocyte Count; Male; Middle Aged; Risk Factors; Tunica Intima	2007
A novel fully enzymatic method for determining glucose and 1,5-anhydro-D-glucitol in serum of one cuvette. Applied biochemistry and biotechnology, 2008, Volume: 150, Issue:3 Topics: Blood Glucose; Chemistry Techniques, Analytical; Deoxyglucose; Diabetes Mellitus, Type 2; Glucokinase; Glucosephosphate Dehydrogenase; Humans; Models, Biological; Reproducibility of Results	2008
IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas. Cytokine, 2008, Volume: 42, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; C-Peptide; Coronary Artery Disease; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Interleukin-12; Lipoproteins, HDL; Male; Middle Aged; Multivariate Analysis; Proinsulin; Regression Analysis; Sulfonylurea Compounds	2008
Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients. Diabetes care, 2008, Volume: 31, Issue:8 Topics: Aged; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Fasting; Humans; Hypoglycemic Agents; Middle Aged; Outpatients; Postprandial Period; Reproducibility of Results; Switzerland	2008
Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1alpha maturity-onset diabetes of the young. Diabetes care, 2008, Volume: 31, Issue:8 Topics: Adult; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Hepatocyte Nuclear Factor 1-alpha; Humans; Male; Middle Aged; Mutation; Poland; Reference Values; Registries; Sex Characteristics	2008
Serum 1,5-anhydro-D-glucitol assay by high performance anion exchange chromatography. British journal of biomedical science, 1994, Volume: 51, Issue:1 Topics: Blood Glucose; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Humans; Reference Values; Specimen Handling	1994
Mannose, mannitol, fructose and 1,5-anhydroglucitol concentrations measured by gas chromatography/mass spectrometry in blood plasma of diabetic patients. Clinica chimica acta; international journal of clinical chemistry, 1996, Jul-15, Volume: 251, Issue:1 Topics: Blood Glucose; Creatinine; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructose; Gas Chromatography-Mass Spectrometry; Humans; Isomerism; Mannitol; Mannose	1996
Effects of age and obesity on glycated haemoglobin and 1,5-anhydroglucitol in screening for type 2 diabetes mellitus. Diabetic medicine : a journal of the British Diabetic Association, 1995, Volume: 12, Issue:10 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Biomarkers; Body Mass Index; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; False Positive Reactions; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Japan; Mass Screening; Middle Aged; Multivariate Analysis; Obesity; Probability; Regression Analysis; Reproducibility of Results; Rural Population; Stereoisomerism	1995
Decreased serum 1,5-anhydroglucitol in nondiabetic subjects with a family history of NIDDM. Diabetes care, 1996, Volume: 19, Issue:9 Topics: Analysis of Variance; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Glycosuria; Humans; Isomerism; Middle Aged; Nuclear Family; Reference Values	1996
Effect of acarbose on blood glucose profiles and plasma 1,5-anhydro-d-glucitol in type 2 diabetes poorly controlled by sulfonylurea therapy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1996, Volume: 50, Issue:6-7 Topics: Acarbose; Aged; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glucose Tolerance Test; Glyburide; Glycosuria; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Trisaccharides	1996
Rapid improvement of serum 1,5-anhydroglucitol concentrations after administration of alpha-glucosidase inhibitor. Diabetes care, 1997, Volume: 20, Issue:3 Topics: Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Inositol; Isomerism; Male; Middle Aged	1997
Decreased activity of arachidonate 12-lipoxygenase in platelets of Japanese patients with non-insulin-dependent diabetes mellitus. Metabolism: clinical and experimental, 1998, Volume: 47, Issue:3 Topics: Adult; Aged; Arachidonate 12-Lipoxygenase; Arachidonic Acid; Blood Glucose; Blood Platelets; Body Mass Index; Cytosol; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Fructose; Glucose; Glycated Hemoglobin; Humans; Male; Middle Aged; Sex Characteristics	1998
Mechanisms of elevation of serum and urinary concentrations of soluble thrombomodulin in diabetic patients: possible application as a marker for vascular endothelial injury. Metabolism: clinical and experimental, 1998, Volume: 47, Issue:3 Topics: Adult; Albuminuria; beta 2-Microglobulin; Blood Glucose; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Solubility; Thrombomodulin	1998
Relationship between serum 1,5-anhydroglucitol and urinary excretion of N-acetylglucosaminidase and albumin determined at onset of NIDDM with 3-year follow-up. Diabetes care, 1998, Volume: 21, Issue:4 Topics: Acetylglucosaminidase; Adult; Albuminuria; Biomarkers; Blood Glucose; Blood Pressure; Blood Proteins; Cholesterol; Cholesterol, HDL; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Follow-Up Studies; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Isomerism; Male; Middle Aged; Prospective Studies; Regression Analysis; Sulfonylurea Compounds; Time Factors; Triglycerides	1998
Economic evaluation of alternative indicators for screening for diabetes mellitus. Preventive medicine, 1999, Volume: 29, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Deoxyglucose; Diabetes Mellitus, Type 2; Fructosamine; Glucose Intolerance; Glycated Hemoglobin; Humans; Male; Mass Screening; Middle Aged; Models, Econometric; Sensitivity and Specificity	1999
Serum 1,5-anhydro-D-glucitol as a new clinical marker for glucose metabolism in type 2 diabetics. Chinese medical journal, 1999, Volume: 112, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose; Humans; Male; Middle Aged	1999
Estimation of plasma glucose fluctuation with a combination test of hemoglobin A1c and 1,5-anhydroglucitol. Metabolism: clinical and experimental, 1992, Volume: 41, Issue:8 Topics: Adult; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycosuria; Hemoglobin A; Humans; Male; Middle Aged; Osmolar Concentration	1992
Serum 1,5-anhydro-D-glucitol and glycemic control in patients with non-insulin-dependent diabetes mellitus. The Tohoku journal of experimental medicine, 1991, Volume: 163, Issue:2 Topics: Adult; Aged; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Models, Biological; Regression Analysis; Time Factors	1991
Plasma 1,5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients. Diabetes, 1989, Volume: 38, Issue:6 Topics: Adult; Aged; Biomarkers; Blood Glucose; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus, Type 2; Fasting; Female; Glycosuria; Humans; Insulin; Male; Middle Aged; Pregnancy; Pregnancy in Diabetics	1989
Changes in relationship between blood glucose level and plasma 1,5-anhydroglucitol level in KK mice. Biochemistry international, 1989, Volume: 18, Issue:3 Topics: Animals; Blood Glucose; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Insulin Resistance; Mice; Mice, Inbred Strains	1989
Urinary excretion of 1,5-anhydro-D-glucitol accompanying glucose excretion in diabetic patients. Diabetologia, 1988, Volume: 31, Issue:11 Topics: Adult; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glycosuria; Humans; Isomerism; Reference Values	1988
Reduction and recovery of plasma 1,5-anhydro-D-glucitol level in diabetes mellitus. Diabetes, 1987, Volume: 36, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Blood Glucose; C-Peptide; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Longitudinal Studies; Male; Middle Aged; Rats	1987